Author

A. Makinson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Neyret· 1 shared C. B. Chesnais· 1 shared C. Boulle· 1 shared C. Chable-Bessia· 1 shared D. Muriaux· 1 shared J. M. Swain· 1 shared M. Henaut· 1 shared N. Gros· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Neyret

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Low selectivity index of ivermectin and macrocyclic lactones on SARS-CoV2 replication in vitro argues against their therapeutic use for COVID-19.

C. Chable-Bessia, C. Boulle, A. Neyret, J. M. Swain, M. Henaut, P. Merida, N. Gros, A. Makinson, S. Lyonnais, C. B. Chesnais, D. Muriaux

This study evaluates the anti-SARS-CoV-2 activity of ivermectin and other macrocyclic lactones in vitro, finding low selectivity indices that suggest limited therapeutic potential for COVID-19.

bioRxiv · Nov 1, 2021 · PreprintMicrobiology